I’ve just had a paper published in Nature Reviews Drug Discovery, using data from DrugPatentWatch to profile the locations of drug invention for the past decade. The location of drug development is important for two reasons. Firstly, it is important to track the global spread of innovation. Much late stage drug development (e.g. clinical trials) and […]
A new report from DrugPatentWatch.com profiles the leading researchers, US states, and countries responsible for drugs approved over the past ten years. The report features: Top Inventors Which inventors were granted the most patents? Patents per Inventor The patents awarded to each inventor Approved Drugs per Inventor The approved drugs protected by each inventor’s patents […]
Once again, the Scientific American WorldView project continues to measure global biotechnology innovation. I had the pleasure of serving as lead editorial consultant of this project, and my mission was to cut through the marketing messages and develop a coherent measure of biotechnology innovation on a country-by-country basis. Visit the WorldView homepage See the country […]
The 2010 version of Scientific American’s Worldview is launching at BIO. I’ve updated last year’s rankings, and also included some new measures. The data section is also significantly expanded, with numerous tables and charts comparing biotechnology activities and supportive elements from around the world. While readers not at BIO2010 will have to wait until the […]
I was recently queried by the Israeli Life Science Industry on my thoughts regarding trends in the global biotechnology industry as well as elements of specific interest to Israel. You can see my full interview at ILSI’s website.
My most recent editorial in the Journal of Commercial Biotechnology, “The impact of the global financial crisis on biotechnology development,” examines the response of governments around the world to their investments in biotechnology and healthcare innovation. It is a theme that I also raised in the Scientific American WorldVIEW. The bottom line is: despite economic […]
Here is a recent keynote I gave for the Delaware Valley Innovation Network. The group is working on coordinating the activities of community colleges — and other parties — between the adjacent Delaware, Philadelphia, and New Jersey regions. My objective was to use case studies to show that drawing circles around regions to count combined […]
After months of preparation, the Scientific American worldVIEW project has launched. I had the pleasure of serving as lead editorial consultant of this project, and my mission was to cut through the marketing messages and develop a coherent measure of biotechnology innovation on a country-by-country basis. You can hear me talk about the project and […]
I’ve got two appearances at BIO related to the Scientific American worldView project: On May 18th I’ll be participating in a press conference at 1pm in room A340 On May 20th I’ll be participating in a roundtable at 3:30 in Thomas B. Murphy Ballroom I, Bldg. B, Level 5. Hope to see you all there!
In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products must “differ significantly in properties with regard to efficacy.” This requirement for a significant improvement in efficacy only applies to drugs — not to other patentable inventions like pens, car engines, etc., and is of […]